Preferred Label : Bosentan;
MeSH definition : A sulfonamide and pyrimidine derivative that acts as a dual endothelin receptor antagonist
used to manage PULMONARY HYPERTENSION and SYSTEMIC SCLEROSIS.;
MeSH synonym : 4-t-Butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide;
MeSH hyponym : Ro 47 0203; Ro 470203; Ro-47-0203;
MeSH CAS label : Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)(2,2'-bipyrimidin)-4-yl)-;
MeSH Related Number : 147536-97-8 (Bosentan); XUL93R30K2;
UNII : Q326023R30;
Origin ID : D000077300;
UMLS CUI : C0252643;
ATC code(s)
ATC code(s)
Allowable qualifiers
MeSH indexing information
Pharmacological action(s)
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
Validated automatic mappings to BTNT
A sulfonamide and pyrimidine derivative that acts as a dual endothelin receptor antagonist
used to manage PULMONARY HYPERTENSION and SYSTEMIC SCLEROSIS.
https://www.has-sante.fr/portail/jcms/c_2839017/fr/bosentan-ohre-pharma
2018
false
false
false
France
French
evaluation of the transparency committee
sulfonamides
Bosentan
---
http://www.has-sante.fr/portail/jcms/c_2740904/fr/bosentan-mylan
2017
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
Bosentan monohydrate 62.5mg tablet (product)
Bosentan monohydrate 125mg tablet (product)
sulfonamides
Bosentan
---
https://www.has-sante.fr/portail/jcms/c_2814693/fr/bosentan-zentiva
2017
false
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
sulfonamides
Bosentan
---
https://www.has-sante.fr/portail/jcms/c_2788630/fr/bosentan-sandoz
2017
false
false
false
France
French
evaluation of the transparency committee
sulfonamides
Bosentan
---
https://www.has-sante.fr/portail/jcms/c_2773803/fr/bosentan-mylan
2017
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
bosentan
Bosentan monohydrate 62.5mg tablet (product)
Bosentan monohydrate 125mg tablet (product)
sulfonamides
Bosentan
---
http://www.has-sante.fr/portail/jcms/c_2740916/fr/bosentan-accord
2017
false
false
false
France
French
evaluation of the transparency committee
Bosentan monohydrate 62.5mg tablet (product)
Bosentan monohydrate 125mg tablet (product)
drugs, generic
sulfonamides
Bosentan
---
http://www.has-sante.fr/portail/jcms/c_2740907/fr/bosentan-teva
2017
false
false
false
France
French
evaluation of the transparency committee
Bosentan monohydrate 62.5mg tablet (product)
Bosentan monohydrate 125mg tablet (product)
drugs, generic
sulfonamides
Bosentan
---
http://www.has-sante.fr/portail/jcms/c_2747505/fr/bosentan-arrow
2017
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
hypertension, pulmonary
sulfonamides
Bosentan
---
https://www.has-sante.fr/portail/jcms/c_2773800/fr/bosentan-teva
2017
false
false
false
France
French
evaluation of the transparency committee
sulfonamides
Bosentan
---
https://www.has-sante.fr/portail/jcms/c_2773809/fr/bosentan-biogaran
2017
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
Bosentan monohydrate 62.5mg tablet (product)
Bosentan monohydrate 125mg tablet (product)
bosentan
sulfonamides
Bosentan
---
https://www.ema.europa.eu/medicines/human/EPAR/Stayveer
2013
false
United Kingdom
English
French
Endothelin A Receptor Antagonists
Endothelin B Receptor Antagonists
Endothelin A Receptor Antagonists
Endothelin B Receptor Antagonists
summary of product characteristics
package leaflet
syndication feed
bosentan
drug approval
europe
hypertension, pulmonary
drug evaluation
scleroderma, systemic
skin ulcer
fingers
toes
administration, oral
adult
breast feeding
Endothelin-1
blood circulation
drug interactions
pregnancy
treatment outcome
drug evaluation, preclinical
Bosentan
Bosentan
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64186770
2012
France
summary of product characteristics
package leaflet
tablets
Bosentan
---
https://www.ema.europa.eu/medicines/human/EPAR/Tracleer
2012
false
United Kingdom
French
English
syndication feed
Endothelin A Receptor Antagonists
Endothelin A Receptor Antagonists
Endothelin B Receptor Antagonists
Endothelin B Receptor Antagonists
adult
child
aged
drug interactions
pregnancy
breast feeding
liver
hemoglobins
drug evaluation, preclinical
drug approval
hypertension, pulmonary
treatment outcome
drug evaluation
administration, oral
orphan drug production
bosentan
drug evaluation
summary of product characteristics
package leaflet
scleroderma, systemic
skin ulcer
blood circulation
Endothelin-1
Bosentan
Bosentan
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-05/synthese_davis_reevaluation_htap_2011-05-12_12-18-35_386.pdf
http://www.has-sante.fr/portail/jcms/c_1053751/medicaments-de-lhypertension-arterielle-pulmonaire-idiopathique-ou-associee-a-une-connectivite
2011
false
France
French
evaluation of the transparency committee
guidelines for drug use
Sildenafil Citrate
Tadalafil
hypertension, pulmonary
collagen diseases
epoprostenol
antihypertensive agents
sulfonamides
treprostinil
epoprostenol
phosphodiesterase 5 inhibitors
iloprost
receptors, endothelin
ambrisentan
phenylpropionates
DERMATITIS
survival analysis
Antihypertensives for pulmonary arterial hypertension
treatment outcome
pyridazines
Bosentan
---
http://www.has-sante.fr/portail/jcms/c_928168/tracleer
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-03/tracleer_-_ct-7227.pdf
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-05/tracleer_ct_7227.pdf
2010
France
French
English
evaluation of the transparency committee
administration, oral
hypertension, pulmonary
orphan drug production
bosentan
treatment outcome
sulfonamides
scleroderma, systemic
skin ulcer
fingers
sulfonamides
Bosentan
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-03/tracleer_-_ct-7227.pdf
http://www.has-sante.fr/portail/jcms/c_946222/tracleer-32-mg-bosentan-antagoniste-des-recepteurs-de-lendotheline
2010
false
France
French
receptor, endothelin b
hypertension, pulmonary
administration, oral
orphan drug production
bosentan
treatment outcome
skin ulcer
scleroderma, systemic
fingers
evaluation of the transparency committee
guidelines for drug use
Bosentan
---
http://www.has-sante.fr/portail/jcms/c_743957/tracleer
http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-02/tracleer_-_ct-6026.pdf
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-05/tracleer_ct_6026.pdf
2009
false
France
French
English
tablets
antihypertensive agents
administration, oral
insurance, health, reimbursement
hypertension, pulmonary
treatment outcome
bosentan
orphan drug production
evaluation of the transparency committee
Bosentan
---
http://www.has-sante.fr/portail/display.jsp?id=c_244413
2003
false
France
French
hypertension, pulmonary
antihypertensive agents
bosentan
guidelines for drug use
Bosentan
---
https://www.cadth.ca/sites/default/files/pdf/108_No21_tracleer_edrug_f.pdf
2002
false
Canada
French
antihypertensive agents
hypertension, pulmonary
treatment outcome
canada
bosentan
drug evaluation
Bosentan
---